← FDA DRUG APPROVALS

FDA ANDA · ANDA078715

LITHIUM CARBONATE

Sponsor: HIKMA INTL PHARMS

APPLICATION
ANDA078715
TYPE
ANDA
ORIGINAL APPROVAL
2010-12-28
LATEST ACTION
2012-03-06
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

LITHIUM CARBONATEDiscontinued
LITHIUM CARBONATE 300MG · TABLET · ORAL

Approval history

2012-03-06Labeling · Supplement 3AP
2010-12-28OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →